July 14-15, 2020 | 9am-6pm EDT | 6am-3pm PDT


Organoids: A Revolutionary New Tool for Drug Screening

Tuesday July 14, 9:10am
Rekha Pal PhD, Director - Scientific Engagement

Key Presentation Takeaways:

  • Discover organoids as a more physiologically relevant 3D in vitro model
  • Find out why HUB organoids are considered a best-in-class system
  • Understand how organoids are revolutionizing oncology drug development
  • Learn how patient-derived xenografts (PDX) can be leveraged to develop the largest organoid library for oncology drug discovery

Poster Presentation

Development of a Bioluminescent Pancreatic Orthotopic KPC Model for Immuno-Oncology Drug Discovery

Tuesday July 14, 3:15pm

Explore the development and characterization of an orthotopic bioluminescent KPC homograft model, compatible with optical imaging to facilitate preclinical evaluation of innovative treatments for PDAC. Discover benchmark efficacy studies, including ICI treatment, model immune profiling, and orthotopic model metastatic potential.


Arrange a Meeting During Virtual Tumor Models Boston

Your privacy is important to us.
We'll never share your information.